Recently, a member of the testican family, testican-1, has been shown to be involved in the proliferation, migration and invasion of cancer cells via the PI3K/Akt and Wnt/β-catenin pathway, and therefore represents a potential therapeutical target [4,5]. This evidence concerns the gene SPOCK1 and cancer.